Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

NEUROFEEDBACK on Event-Related Potential (ERP) (MyB)

28 de outubro de 2019 atualizado por: Hospices Civils de Lyon

Clinical Evaluation of a Brain Computer Interfaces (BCI)-Based Training of Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This project aims to assess the evolution of symptoms in ADHD children from 8 to 17 years, with various types of attention training.

Different groups A, B and C will be evaluated: the first with Neurofeedback training, the second with a similar training but not indexed on brain activity and the third without training.

30 patients will be randomly assigned to groups A and B according to a ratio 2:1.

Others patients who meet the same criteria but for logistical reasons cannot comply with the training constraints will be assigned to group C.

Children included in groups A and B will participate in training sessions (Neurofeedback and control training, respectively) as well as in four evaluation sessions. Children in group C will only participate in evaluation sessions (baseline control group).

Patients of groups A and B will be followed over 6 months: 4 months of training and a follow-up evaluation 2 months after training.

Patients of group C will be followed each 2 months for 6 months. This study uses electro-encephalography measures, serious video game, neuropsychological tests and questionnaires.

It also uses actigraphy measures to evaluate sleep quality.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Real)

52

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

  • França
      • Bron, França, 69500
        • Hospices Civils de Lyon

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

8 anos a 17 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Children and teenagers aged from 8 to 17 years' old
  • Children and teenagers with a deficit attention disorder with or without hyperactivity, in the mixed form or in a pure inattentive form according to Diagnostique et Statistique des troubles Mentaux (DSM)-V.
  • Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) ≥ 80 of WISC IV or V test, not older than two years.
  • Children and teenagers without psychostimulant treatment
  • Children and teenagers with psychostimulant treatment agreed to achieve a therapeutic break at each visit day and with a stable dose during all the study.
  • Children and teenagers whose parents have agreed and signed informed consent form of the study.

Exclusion Criteria:

  • Children aged less than 8 and teenagers are more than 18 years' old.
  • Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) < 80 of WISC IV or V test, not older than two years.
  • Children and teenagers with developmental disorder except "Dys" disorders.
  • Children and teenagers with pure hyperactivity (without attentional deficit)
  • Children and teenagers with epilepsy except benign epilepsies (without brain damage), free of crisis for two years and without treatment.
  • Children and teenagers with ADHD with conduct disorders and aggression
  • Children and teenagers with ADHD and Tourette's syndrome.
  • Patients treated by anti / epilepsy or psychotropic treatments (with the exception of psychostimulant treatment).
  • Patients with psychostimulant treatment and whose parents aren't agreed to achieve a therapeutic break at each visit day.
  • Patients with visual deficiency uncorrectable with lenses or glasses.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Triplo

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Group A

Children will be assigned to this group in a random fashion according to a ratio 2:1 with respect to group B (see below).

20 subjects will be included in this group.
Outro: Neurofeedback training

Children in group A will receive BCI-based training implemented through original P300-based controlled games.

They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.

Each session includes: installation of the child, the EEG system and an eye-tracking system, a 5-minutes relaxation phase, a short EEG recording at rest, a brief reminder of the instructions, 30 minutes of training by playing video games and finally a time for the child to wash her/his hair.

Moreover, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be answered.
Comparador Ativo: Group B
Children will be assigned in this group in a random fashion. 10 subjects will be included in this group.
Outro: Active Sham control

Children in group B will receive a training that is not based on brain activity, but in a blind fashion. They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.

Each session includes: installation of the child, setting up the EEG and eye-tracking systems, a 5-minutes relaxation phase, short EEG recording at rest, a brief reminder of the instructions, 30 minutes of video game based training and finally a time for the child to wash her/his hair.

Besides, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be performed.
Comparador Ativo: Group C

Will be included in this group children who meet the inclusion criteria and who, with their families, are motivated to participate in the study but cannot claim to be part of groups A or B (because of logistical constraints: living too far away to comply with the frequency of the visits required by the training).

Group C allows to follow the natural evolution of children with ADHD with no intervention.
Outro: Baseline control group
The children included in this group will not receive any training. They only take part to the 4 neuropsychological sessions. Like others, they will attend 1 neuropsychological session every two months over six months.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Evaluation of the relative effect on symptoms of inattention between the two proposed training techniques, A and B, with the ADHD Rating Scale in children with ADHD
Prazo: every two months over six months.
Questions with odd numbers interested in the dimension "inattentive" will particularly be studied. The investigator expect an improvement in the type of score: ''ADHD-Inattentive'' children in group A compared to children in Group B. More specifically, he expect to improve responses to questions number 1,3,5,7,9,11,13,15 and 17. By definition, an evolving response would be to move from " 2=Often; 3=Very often" to " 1=Sometimes; 0=Rarely/Never".
every two months over six months.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
Bron/Lyon Attention Stability test (BLAST) test will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
Wechsler Intelligence Scale for Children (WISC) subtests will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
Wechsler Intelligence Scale for Children (WISC) will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children
Prazo: every months over six months.
Bron/Lyon Attention Stability test (BLAST) will be performed ADHD children from groups A, B and C will be compared
every months over six months.
Compare the effects of the two types of trainings on the hyperactivity symptoms in ADHD children using neuropsychological assessments.
Prazo: every two months over six months
ADHD Rating Scale (questions with even numbers), Test d'évaluation de l'Attention (TAP) and Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children
Prazo: every two months over six months
Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children
Prazo: every two months over six months
Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children
Prazo: every two months over six months
ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children
Prazo: every two months over six months
Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
CPT will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
CPT will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
CPT will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP))
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR)
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR)
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
TAP will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
BLAST will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups.
Prazo: every two months over six months
Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared
every two months over six months
Evaluate the impact of the trainings on the sleep quality in ADHD children.
Prazo: every two months over six months.
Sleep questionnaires will be distributed ADHD children in groups A, B and C will be compared.
every two months over six months.
Evaluate the impact of the trainings on the sleep quality in ADHD children.
Prazo: every two months over six months.
The sleep data may also be collected using an actigraph (ancillary study). ADHD children in groups A, B and C will be compared.
every two months over six months.
Evaluating the impact of the trainings on the quality of life in ADHD children.
Prazo: every two months over six months

The Child Behavior CheckList (CBCL) questionnaire will be performed

Groups A, B and C will be compared.
every two months over six months
Evaluating the impact of the trainings on the quality of life in ADHD children.
Prazo: every two months over six months

Information about the quality of life will be also collected in a logbook by family members and provided at each visit.

Groups A, B and C will be compared.
every two months over six months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Hospices Civils de Lyon

Investigadores

  • Investigador principal: Alexis ARZIMANOGLOU, Hospices Civils de Lyon

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

2 de fevereiro de 2017

Conclusão Primária (Real)

9 de setembro de 2019

Conclusão do estudo (Real)

9 de setembro de 2019

Datas de inscrição no estudo

Enviado pela primeira vez

4 de agosto de 2017

Enviado pela primeira vez que atendeu aos critérios de CQ

18 de setembro de 2017

Primeira postagem (Real)

21 de setembro de 2017

Atualizações de registro de estudo

Última Atualização Postada (Real)

29 de outubro de 2019

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de outubro de 2019

Última verificação

1 de outubro de 2019

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 69HCL15_0214

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Neurofeedback training

Pesquisar ensaios semelhantes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

CROs by country

CROs in Papua New Guinea

Condições

Doenças Raras

Intervenções de drogas

Suplementos Alimentares

Patrocinador / Colaboradores

Localizações

3
Se inscrever